Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year.
Synsam AB's 1-Year ROIIC % for the quarter that ended in Mar. 2026 was 72.11%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Synsam AB's 1-Year ROIIC % or its related term are showing as below:
CHIX:SYNSAs's 1-Year ROIIC % is ranked better than 83.37% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 0.745
vs CHIX:SYNSAs: 72.11
Synsam AB (CHIX:SYNSAs) 1-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Synsam AB 1-Year ROIIC % Related Terms
Synsam AB 1-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Synsam AB's 1-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SYNSAS vs ISRG, BDX, MDLN: 1-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Synsam AB's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synsam AB 1-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Synsam AB's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Synsam AB's 1-Year ROIIC % falls into.
Synsam AB's 1-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
1-Year ROIIC %
=
1-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
1-Year Incremental Invested Capital
=
( 679.0804 (Mar. 2026) - 607.6882 (Mar. 2025) )
/
( 7518 (Mar. 2026) - 7419 (Mar. 2025) )
=
71.3922
/
99
=
72.11%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Synsam AB (CHIX:SYNSAS) has a 1-Year ROIIC % of 72.11 as of Mar. 2026. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Synsam AB and its competitors. According to the industry distribution chart, Synsam AB ranks #136 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 16.6%.
Is Synsam AB's 1-Year ROIIC % too high?
Synsam AB's current 1-Year ROIIC % is 72.11. The Medical Devices & Instruments industry median 1-Year ROIIC % is 0.75. Synsam AB's value of 72.11 is 9579.2% above this industry median. Based on the distribution chart, Synsam AB ranks #136 out of 818 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Synsam AB has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Synsam AB's 1-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Synsam AB ranks #136 out of 818 companies for 1-Year ROIIC %. This places Synsam AB in the top 17% of its industry — outperforming the majority of peers. The industry median 1-Year ROIIC % is 0.75. Synsam AB's value of 72.11 is 9579.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year ROIIC % for a Medical Devices & Instruments company?
The median 1-Year ROIIC % among Medical Devices & Instruments companies is 0.75, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a 1-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 1-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synsam AB's current 1-Year ROIIC % of 72.11 is 9579.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year ROIIC % mean?
A high 1-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Synsam AB and its competitors. For the Medical Devices & Instruments industry, the median 1-Year ROIIC % is 0.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synsam AB's current 1-Year ROIIC % is 72.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synsam AB stock overvalued right now?
Synsam AB (CHIX:SYNSAS) has a current 1-Year ROIIC % of 72.11. The stock's GF Value™ is kr64.34, compared to a current price of kr59.80 — trading 7.1% below its estimated fair value. The current 1-Year ROIIC % is 72.11 and 9579.2% above the Medical Devices & Instruments industry median of 0.75. Synsam AB's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year ROIIC % calculated?
1-Year ROIIC % is calculated from a company's financial statements. For Synsam AB (CHIX:SYNSAS), the current 1-Year ROIIC % is 72.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synsam AB (CHIX:SYNSAS) Overvalued in 2026?
Based on GuruFocus' analysis, Synsam AB stock appears to be undervalued.
The current stock price of kr59.80 is trading 7.1% below its estimated GF Value™ of kr64.34.
Key valuation signals for CHIX:SYNSAS:
1-Year ROIIC %: 72.11
GF Value™: kr64.34 vs. price of kr59.80 (7.1% below fair value)
Industry Position: 9579.2% above the Medical Devices & Instruments median (#136 of 818)
No single metric tells the full story. See the CHIX:SYNSAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synsam AB is a lifestyle company in optics and eye health in the Nordic region. The company offers various products and services in physical and digital stores, such as eye examinations, spectacles, sunglasses, sports spectacles, contact lenses, and accessories in optical retail, as well as spectacles subscriptions and related services under the name Synsam Lifestyle. Its stores are operated under the Synsam brand in Sweden, Norway, and Finland, and under the Profil Optik brand in Denmark and Iceland. The company comprises four segments: Sweden, which generates key revenue, Denmark, Norway, and Finland.
85GF Score
Get the complete analysis for CHIX:SYNSAS
1-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SYNSAS has been successfully added to your 
